Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Aldehyde doai
Patent
1992-06-09
1994-03-01
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Aldehyde doai
568439, A61K 3111, C07C 4752
Patent
active
052908178
ABSTRACT:
The invention relates to benzylindane phospholipase A.sub.2 inhibitors, pharmaceutical compositions containing them, and methods of treating phospholipase A.sub.2 -mediated conditions in mammals by administration of a therapeutically effective amount of such a benzylindane phospholipase A.sub.2 inhibitor including the representative example: ##STR1##
REFERENCES:
patent: 3399049 (1968-08-01), Evans et al.
patent: 3904691 (1975-09-01), Carnmalm et al.
Chemical Abstracts 111: 190105, 1989.
Chemical Abstracts 77: 151743, 1972.
Chemical Abstracts 71: 70392, 1968.
Chemical Abstracts 70: 3838, 1968.
Chemical Abstracts 68: 75556, 1968.
Boudreaux Gerald J.
Cintins Marianne M.
Scalzo Catherine
The Du Pont Merck Pharmaceutical Co.
LandOfFree
Substituted 1-benzylindanes and their use as inhibitors of phosp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1-benzylindanes and their use as inhibitors of phosp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-benzylindanes and their use as inhibitors of phosp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577717